| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGILE THERAPEUTICS INC | Director | Common Stock | 2,241 | $1,905 | $0.8500 | 09 Jun 2022 | Direct |
| AGILE THERAPEUTICS INC | Director | Employee Stock Option (Right to Buy) | 807 | 09 Jun 2022 | Direct | ||
| Actinium Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | 31 Mar 2025 | Direct | ||
| Actinium Pharmaceuticals, Inc. | Director | tock Option (Right to Buy) | 0 | 31 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | 31 Mar 2025 | 7 | $0 | 4 | Director | 02 Apr 2025, 18:21 |
| ATNM | Actinium Pharmaceuticals, Inc. | 28 Dec 2023 | 1 | $0 | 4 | Director | 29 Dec 2023, 17:18 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 19:14 |
| AGRX | AGILE THERAPEUTICS INC | 09 Jun 2022 | 2 | $0 | 4 | Director | 10 Jun 2022, 16:46 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Sep 2021 | 1 | $0 | 4 | Director | 03 Sep 2021, 17:03 |
| AGRX | AGILE THERAPEUTICS INC | 08 Jun 2021 | 2 | $0 | 4 | Director | 10 Jun 2021, 19:10 |